Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

A mobile app for patients with Pompe disease and its possible clinical applications.

Ricci G, Baldanzi S, Seidita F, Proietti C, Carlini F, Peviani S, Antonini G, Vianello A, Siciliano G; Italian GSD II group.

Neuromuscul Disord. 2018 Jun;28(6):471-475. doi: 10.1016/j.nmd.2018.03.005. Epub 2018 Mar 12.

PMID:
29655528
2.

Development of a Device-Assisted Nerve-Regeneration Procedure in Disruptive Lesions of the Brachial Plexus.

Merolli A, Manunta ML, Mao Y, Masala G, Careddu GM, Cubeddu F, Evangelisti MA, Guida ML, Verardi CA, Proietti C, Manunta A, D'Urso Labate GF, Catapano G, Polunas M, Louro P, Passino ES.

J Reconstr Microsurg. 2018 Jul;34(6):389-398. doi: 10.1055/s-0038-1627472. Epub 2018 Mar 6.

PMID:
29510417
3.

Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome.

Liu Z, Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Yu KJ, Lou PJ, Wang CP, Mulvenna J, Middeldorp JM, Bethony J, Chen CJ, Doolan DL, Hildesheim A.

J Infect Dis. 2018 May 25;217(12):1923-1931. doi: 10.1093/infdis/jiy122.

PMID:
29509907
4.

Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions.

Proietti CJ, Cenciarini ME, Elizalde PV.

Steroids. 2018 May;133:75-81. doi: 10.1016/j.steroids.2017.12.015. Epub 2018 Jan 6. Review.

PMID:
29317254
5.

Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.

Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Teng A, Pablo J, Yu KJ PhD, Lou PJ MD, Wang CP, Liu Z, Chen CJ, Middeldorp J, Mulvenna J, Bethony J, Hildesheim A, Doolan DL.

Clin Cancer Res. 2018 Mar 15;24(6):1305-1314. doi: 10.1158/1078-0432.CCR-17-1929. Epub 2018 Jan 4.

PMID:
29301829
6.

Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.

Mercogliano MF, Inurrigarro G, De Martino M, Venturutti L, Rivas MA, Cordo-Russo R, Proietti CJ, Fernández EA, Frahm I, Barchuk S, Allemand DH, Figurelli S, Deza EG, Ares S, Gercovich FG, Cortese E, Amasino M, Guzmán P, Roa JC, Elizalde PV, Schillaci R.

BMC Cancer. 2017 Dec 28;17(1):895. doi: 10.1186/s12885-017-3897-x.

7.

Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ERα-GREB1 Transcriptional Axis.

Wu Y, Zhang Z, Cenciarini ME, Proietti CJ, Amasino M, Hong T, Yang M, Liao Y, Chiang HC, Kaklamani VG, Jeselsohn R, Vadlamudi RK, Huang TH, Li R, De Angelis C, Fu X, Elizalde PV, Schiff R, Brown M, Xu K.

Cancer Res. 2018 Feb 1;78(3):671-684. doi: 10.1158/0008-5472.CAN-17-1327. Epub 2017 Dec 6.

8.

The role of plant phenology in stomatal ozone flux modeling.

Anav A, Liu Q, De Marco A, Proietti C, Savi F, Paoletti E, Piao S.

Glob Chang Biol. 2018 Jan;24(1):235-248. doi: 10.1111/gcb.13823. Epub 2017 Aug 17.

PMID:
28722275
9.

Poplar response to cadmium and lead soil contamination.

Radojčić Redovniković I, De Marco A, Proietti C, Hanousek K, Sedak M, Bilandžić N, Jakovljević T.

Ecotoxicol Environ Saf. 2017 Oct;144:482-489. doi: 10.1016/j.ecoenv.2017.06.011. Epub 2017 Jun 28.

PMID:
28667860
10.

High resolution estimates of the corrosion risk for cultural heritage in Italy.

De Marco A, Screpanti A, Mircea M, Piersanti A, Proietti C, Fornasier MF.

Environ Pollut. 2017 Jul;226:260-267. doi: 10.1016/j.envpol.2017.03.066. Epub 2017 Apr 2.

PMID:
28381348
11.

Calypso: a user-friendly web-server for mining and visualizing microbiome-environment interactions.

Zakrzewski M, Proietti C, Ellis JJ, Hasan S, Brion MJ, Berger B, Krause L.

Bioinformatics. 2017 Mar 1;33(5):782-783. doi: 10.1093/bioinformatics/btw725.

12.

Mining, visualizing and comparing multidimensional biomolecular data using the Genomics Data Miner (GMine) Web-Server.

Proietti C, Zakrzewski M, Watkins TS, Berger B, Hasan S, Ratnatunga CN, Brion MJ, Crompton PD, Miles JJ, Doolan DL, Krause L.

Sci Rep. 2016 Dec 6;6:38178. doi: 10.1038/srep38178.

13.

TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer.

Mercogliano MF, De Martino M, Venturutti L, Rivas MA, Proietti CJ, Inurrigarro G, Frahm I, Allemand DH, Deza EG, Ares S, Gercovich FG, Guzmán P, Roa JC, Elizalde PV, Schillaci R.

Clin Cancer Res. 2017 Feb 1;23(3):636-648. doi: 10.1158/1078-0432.CCR-16-0970. Epub 2016 Oct 3.

14.

Impacts of air pollution on cultural heritage corrosion at European level: What has been achieved and what are the future scenarios.

Di Turo F, Proietti C, Screpanti A, Fornasier MF, Cionni I, Favero G, De Marco A.

Environ Pollut. 2016 Nov;218:586-594. doi: 10.1016/j.envpol.2016.07.042. Epub 2016 Aug 10.

PMID:
27522406
15.

MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.

Venturutti L, Cordo Russo RI, Rivas MA, Mercogliano MF, Izzo F, Oakley RH, Pereyra MG, De Martino M, Proietti CJ, Yankilevich P, Roa JC, Guzmán P, Cortese E, Allemand DH, Huang TH, Charreau EH, Cidlowski JA, Schillaci R, Elizalde PV.

Oncogene. 2016 Dec 1;35(48):6189-6202. doi: 10.1038/onc.2016.151. Epub 2016 May 9.

16.

Understanding the Missing Link Between Musical Attitudes, Preferences and Psychological Profiles: Music as Auto-Medication and Self-Administered Therapy? Implications for Music Therapy.

Bragazzi NL, Ratto G, Luche ND, Canfori T, Proietti C, Del Puente G.

Health Psychol Res. 2015 Nov 30;3(3):1545. doi: 10.4081/hpr.2015.1545. eCollection 2015 Nov 30. No abstract available.

17.

A multi-sites analysis on the ozone effects on Gross Primary Production of European forests.

Proietti C, Anav A, De Marco A, Sicard P, Vitale M.

Sci Total Environ. 2016 Jun 15;556:1-11. doi: 10.1016/j.scitotenv.2016.02.187. Epub 2016 Mar 11.

PMID:
26971205
18.

Role of hypoxia-related proteins in invasion of ameloblastoma cells: crosstalk between NOTCH1, hypoxia-inducible factor 1α, a disintegrin and metalloproteinase 12, and heparin-binding epidermal growth factor.

da Costa NM, Fialho AD, Proietti CC, da Silva Kataoka MS, Jaeger RG, de Alves-Júnior SM, de Jesus Viana Pinheiro J.

Histopathology. 2016 Jul;69(1):99-106. doi: 10.1111/his.12922. Epub 2016 Feb 25.

PMID:
26707922
19.

Serology describes a profile of declining malaria transmission in Farafenni, The Gambia.

van den Hoogen LL, Griffin JT, Cook J, Sepúlveda N, Corran P, Conway DJ, Milligan P, Affara M, Allen SJ, Proietti C, Ceesay SJ, Targett GA, D'Alessandro U, Greenwood B, Riley EM, Drakeley C.

Malar J. 2015 Oct 22;14:416. doi: 10.1186/s12936-015-0939-1.

20.

Comparing concentration-based (AOT40) and stomatal uptake (PODY) metrics for ozone risk assessment to European forests.

Anav A, De Marco A, Proietti C, Alessandri A, Dell'Aquila A, Cionni I, Friedlingstein P, Khvorostyanov D, Menut L, Paoletti E, Sicard P, Sitch S, Vitale M.

Glob Chang Biol. 2016 Apr;22(4):1608-27. doi: 10.1111/gcb.13138. Epub 2016 Jan 6.

PMID:
26492093
21.

Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth.

Proietti CJ, Izzo F, Díaz Flaqué MC, Cordo Russo R, Venturutti L, Mercogliano MF, De Martino M, Pineda V, Muñoz S, Guzmán P, Roa JC, Schillaci R, Elizalde PV.

Mol Endocrinol. 2015 Oct;29(10):1468-85. doi: 10.1210/me.2015-1170. Epub 2015 Sep 4.

22.

Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.

Venturutti L, Romero LV, Urtreger AJ, Chervo MF, Cordo Russo RI, Mercogliano MF, Inurrigarro G, Pereyra MG, Proietti CJ, Izzo F, Díaz Flaqué MC, Sundblad V, Roa JC, Guzmán P, Bal de Kier Joffé ED, Charreau EH, Schillaci R, Elizalde PV.

Oncogene. 2016 Apr 28;35(17):2208-22. doi: 10.1038/onc.2015.281. Epub 2015 Jul 27.

PMID:
26212010
23.

The case for a rational genome-based vaccine against malaria.

Proietti C, Doolan DL.

Front Microbiol. 2015 Jan 22;5:741. doi: 10.3389/fmicb.2014.00741. eCollection 2014. Review.

24.

Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.

Izzo F, Mercogliano F, Venturutti L, Tkach M, Inurrigarro G, Schillaci R, Cerchietti L, Elizalde PV, Proietti CJ.

Breast Cancer Res. 2014 Dec 6;16(6):491. doi: 10.1186/s13058-014-0491-x.

25.

Genome-based vaccine design: the promise for malaria and other infectious diseases.

Doolan DL, Apte SH, Proietti C.

Int J Parasitol. 2014 Oct 15;44(12):901-13. doi: 10.1016/j.ijpara.2014.07.010. Epub 2014 Sep 6. Review.

26.

Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.

Cordo Russo RI, Béguelin W, Díaz Flaqué MC, Proietti CJ, Venturutti L, Galigniana N, Tkach M, Guzmán P, Roa JC, O'Brien NA, Charreau EH, Schillaci R, Elizalde PV.

Oncogene. 2015 Jun;34(26):3413-28. doi: 10.1038/onc.2014.272. Epub 2014 Sep 1.

PMID:
25174405
27.

Future impacts of nitrogen deposition and climate change scenarios on forest crown defoliation.

De Marco A, Proietti C, Cionni I, Fischer R, Screpanti A, Vitale M.

Environ Pollut. 2014 Nov;194:171-180. doi: 10.1016/j.envpol.2014.07.027. Epub 2014 Aug 12.

PMID:
25118942
28.

Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.

Panebianco V, Barchetti F, Musio D, De Felice F, Proietti C, Indino EL, Megna V, Schillaci O, Catalano C, Tombolini V.

Biomed Res Int. 2014;2014:827265. doi: 10.1155/2014/827265. Epub 2014 Mar 13. Review.

29.

Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.

Díaz Flaqué MC, Galigniana NM, Béguelin W, Vicario R, Proietti CJ, Russo R, Rivas MA, Tkach M, Guzmán P, Roa JC, Maronna E, Pineda V, Muñoz S, Mercogliano M, Charreau EH, Yankilevich P, Schillaci R, Elizalde PV.

Breast Cancer Res. 2013 Dec 17;15(6):R118. doi: 10.1186/bcr3587.

30.

Influence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda.

Proietti C, Verra F, Bretscher MT, Stone W, Kanoi BN, Balikagala B, Egwang TG, Corran P, Ronca R, Arcà B, Riley EM, Crisanti A, Drakeley C, Bousema T.

Parasite Immunol. 2013 May-Jun;35(5-6):164-73. doi: 10.1111/pim.12031.

31.

p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth.

Tkach M, Rosemblit C, Rivas MA, Proietti CJ, Díaz Flaqué MC, Mercogliano MF, Beguelin W, Maronna E, Guzmán P, Gercovich FG, Deza EG, Elizalde PV, Schillaci R.

Endocr Relat Cancer. 2013 Mar 22;20(2):197-212. doi: 10.1530/ERC-12-0194. Print 2013 Apr.

PMID:
23329648
32.

Progestin drives breast cancer growth by inducing p21(CIP1) expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2.

Diaz Flaqué MC, Vicario R, Proietti CJ, Izzo F, Schillaci R, Elizalde PV.

Steroids. 2013 Jun;78(6):559-67. doi: 10.1016/j.steroids.2012.11.003. Epub 2012 Nov 21.

PMID:
23178160
33.

Assessing ozone and nitrogen impact on net primary productivity with a Generalised non-Linear Model.

De Marco A, Screpanti A, Attorre F, Proietti C, Vitale M.

Environ Pollut. 2013 Jan;172:250-63. doi: 10.1016/j.envpol.2012.08.015. Epub 2012 Oct 16.

PMID:
23078996
34.

Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.

Tkach M, Coria L, Rosemblit C, Rivas MA, Proietti CJ, Díaz Flaqué MC, Beguelin W, Frahm I, Charreau EH, Cassataro J, Elizalde PV, Schillaci R.

J Immunol. 2012 Aug 1;189(3):1162-72. doi: 10.4049/jimmunol.1102538. Epub 2012 Jun 29.

35.

The molecular basis of progesterone receptor action in breast carcinogenesis.

Elizalde PV, Proietti CJ.

Horm Mol Biol Clin Investig. 2012 Apr;9(2):105-17. doi: 10.1515/hmbci-2011-0129.

PMID:
25436702
36.

Influence of conformationally restricted pyrimidines on the activity of 10-23 DNAzymes.

Robaldo L, Izzo F, Dellafiore M, Proietti C, Elizalde PV, Montserrat JM, Iribarren AM.

Bioorg Med Chem. 2012 Apr 15;20(8):2581-6. doi: 10.1016/j.bmc.2012.02.047. Epub 2012 Feb 28.

PMID:
22429508
37.

Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer.

Schillaci R, Guzmán P, Cayrol F, Beguelin W, Díaz Flaqué MC, Proietti CJ, Pineda V, Palazzi J, Frahm I, Charreau EH, Maronna E, Roa JC, Elizalde PV.

BMC Cancer. 2012 Feb 22;12:74. doi: 10.1186/1471-2407-12-74.

38.

Serum IgE reactivity profiling in an asthma affected cohort.

Dottorini T, Sole G, Nunziangeli L, Baldracchini F, Senin N, Mazzoleni G, Proietti C, Balaci L, Crisanti A.

PLoS One. 2011;6(8):e22319. doi: 10.1371/journal.pone.0022319. Epub 2011 Aug 4.

39.

Continuing intense malaria transmission in northern Uganda.

Proietti C, Pettinato DD, Kanoi BN, Ntege E, Crisanti A, Riley EM, Egwang TG, Drakeley C, Bousema T.

Am J Trop Med Hyg. 2011 May;84(5):830-7. doi: 10.4269/ajtmh.2011.10-0498.

40.

Plasmodium ovale curtisi and Plasmodium ovale wallikeri circulate simultaneously in African communities.

Oguike MC, Betson M, Burke M, Nolder D, Stothard JR, Kleinschmidt I, Proietti C, Bousema T, Ndounga M, Tanabe K, Ntege E, Culleton R, Sutherland CJ.

Int J Parasitol. 2011 May;41(6):677-83. doi: 10.1016/j.ijpara.2011.01.004. Epub 2011 Feb 23.

41.

Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer.

Proietti CJ, Béguelin W, Flaqué MC, Cayrol F, Rivas MA, Tkach M, Charreau EH, Schillaci R, Elizalde PV.

Steroids. 2011 Mar;76(4):381-92. doi: 10.1016/j.steroids.2010.12.008. Epub 2010 Dec 22. Erratum in: Steroids. 2011 Nov;76(12):1407.

PMID:
21184768
42.

Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3.

Béguelin W, Díaz Flaqué MC, Proietti CJ, Cayrol F, Rivas MA, Tkach M, Rosemblit C, Tocci JM, Charreau EH, Schillaci R, Elizalde PV.

Mol Cell Biol. 2010 Dec;30(23):5456-72. doi: 10.1128/MCB.00012-10. Epub 2010 Sep 27.

43.

[Evaluation of the effectiveness of occupational safety and health inspections of construction sites in the Piedmont region from 2001 to 2005].

Bruno S, Bena A, Debernardi ML, Nava S, Pastore R, Proietti C, Quarta D.

Med Lav. 2009;100 Suppl 1:7-10. Italian.

PMID:
19848093
44.

Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation.

Rivas MA, Tkach M, Beguelin W, Proietti CJ, Rosemblit C, Charreau EH, Elizalde PV, Schillaci R.

Breast Cancer Res Treat. 2010 Jul;122(1):111-24. doi: 10.1007/s10549-009-0546-3. Epub 2009 Sep 18.

PMID:
19760502
45.

Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth.

Proietti CJ, Rosemblit C, Beguelin W, Rivas MA, Díaz Flaqué MC, Charreau EH, Schillaci R, Elizalde PV.

Mol Cell Biol. 2009 Mar;29(5):1249-65. doi: 10.1128/MCB.00853-08. Epub 2008 Dec 22.

46.

Temporal and spatial distribution of Toxoplasma gondii differentiation into Bradyzoites and tissue cyst formation in vivo.

Di Cristina M, Marocco D, Galizi R, Proietti C, Spaccapelo R, Crisanti A.

Infect Immun. 2008 Aug;76(8):3491-501. doi: 10.1128/IAI.00254-08. Epub 2008 May 27.

47.

TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.

Rivas MA, Carnevale RP, Proietti CJ, Rosemblit C, Beguelin W, Salatino M, Charreau EH, Frahm I, Sapia S, Brouckaert P, Elizalde PV, Schillaci R.

Exp Cell Res. 2008 Feb 1;314(3):509-29. Epub 2007 Oct 13.

PMID:
18061162
48.

An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo.

Rachini A, Pietrella D, Lupo P, Torosantucci A, Chiani P, Bromuro C, Proietti C, Bistoni F, Cassone A, Vecchiarelli A.

Infect Immun. 2007 Nov;75(11):5085-94. Epub 2007 Jul 2.

49.

A biophysical investigation on the binding and controlled DNA release in a cetyltrimethylammonium bromide-sodium octyl sulfate cat-anionic vesicle system.

Bonincontro A, La Mesa C, Proietti C, Risuleo G.

Biomacromolecules. 2007 Jun;8(6):1824-9. Epub 2007 May 15.

PMID:
17500529
50.

Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.

Carnevale RP, Proietti CJ, Salatino M, Urtreger A, Peluffo G, Edwards DP, Boonyaratanakornkit V, Charreau EH, Bal de Kier Joffé E, Schillaci R, Elizalde PV.

Mol Endocrinol. 2007 Jun;21(6):1335-58. Epub 2007 Apr 17.

PMID:
17440047

Supplemental Content

Loading ...
Support Center